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In this issue of Cell Reports, Shah et al. present evidence that a subcomplex of the eIF3 transla-
tion initiation factor regulates translation of mRNAs encoding components of the mitochondrial
electron transport chain and glycolytic enzymes, thus linking translational control with energy
metabolism.Translation initiation in eukaryotic cells
requires ribosomal subunits and a num-
ber of ancillary proteins called eukaryotic
initiation factors (eIFs). There are at
least nine eIFs that are composed of be-
tween 1 and 13 polypeptides (Jackson
et al., 2010). Although these elements
are involved in the translation of every
mRNA, evidence is accumulating that
some ribosomal proteins (Xue and Barna,
2012) and eIFs, such as eIF3 (Choudhuri
et al., 2013; Lee et al., 2015), regulate
the translation of specific mRNA subsets.
The gene-specific roles of ribosomal pro-
teins and translation factors are not well
understood.
eIF3 functions as a scaffold required
for multiple processes of translation initia-
tion. eIF3 individual subunits are over- or
under-expressed in many cancers, and
these changes in expression may affect
tumor progression (Hershey, 2015).More-
over, deletion of certain subunits causes
developmental defects in zebra fish
(Choudhuri et al., 2010). However, how
eIF3 malfunction is linked to oncogenic
or developmental phenotypes is not un-
derstood. Although only 6 of the 13 eIF3
mammalian subunits are conserved in
Saccharomyces cerevisiae, the fission
yeast Schizosaccharomyces pombe con-
tains ten subunits that form two distinct
complexes, making S. pombe an excel-
lent system for investigating the function
of non-core subunits of eIF3.
In this issue of Cell Reports, Shah et al.
(2016) find that S. pombe cells lacking
the non-essential eif3e gene (or its part-
ner, eif3d) have general defects in transla-
tion initiation. To identify mRNAs whose
translation is affected in the mutants, theThis is an open access arauthors performed mass spectrometry
analyses of the 80S ribosome-associated
proteome, assuming it would be enriched
in newly synthesized proteins. This anal-
ysis revealed decreased abundance of
mitochondrial respiration complex sub-
units as well as increases in the levels
of proteins involved in glycolysis,
alcohol fermentation, and the tricarbox-
ylic acid cycle. Transcriptomic experi-
ments confirmed that changes in pro-
tein expression between wild-type and
mutant cells were not correlated with
altered mRNA levels. Finally, these results
were confirmed by pulse-SILAC and
direct measurement of synthesis rates of
a subset of 80S-associated proteins.
The proteomic analysis pointed to a role
of eIF3e in the regulation of metabolism.
Indeed, a comprehensive metabolomic
approach revealed that eif3e-deleted
cells have reduced rates of mitochondrial
oxygen consumption and show enhanced
glucose uptake, suggesting a switch from
respiration to glycolysis. These effects
were physiologically relevant, given that
eif3e-deleted cells were unable to grow
at low glucose concentrations or use a
non-fermentable carbon source. These
cells also showed endogenous oxidative
stress and premature aging. The authors
also found that eIF3e protein levels were
elevated under conditions that induce
respiration. Thus, eIF3e appears to be
essential for regulating the balance be-
tween respiration and glycolysis.
Is this regulatory function conserved in
higher eukaryotes? eIF3e is present in hu-
mans and S. pombe (although it is absent
in S. cerevisiae). Shah et al. (2016) found
that eIF3e knockdown on two humanCell
ticle under the CC BY-NC-ND license (http://crcell lines caused a reduction in the protein
levels (but not mRNA) of two components
of the mitochondrial respiratory chain.
A reporter system containing the 50 UTR
of these genes showed a similar behavior,
strongly suggesting that eIF3e regu-
lates the expression of these genes by
modulating their translational efficiency.
Consistently, eIF3e coimmunoprecipi-
tated with mRNAs encoding components
of the mitochondrial respiratory chain.
The observation that initiation factors
regulate the translation of particular
mRNA sets poses a number of mecha-
nistic and physiological questions:
First, which are the mRNAs regulated
by eIF3, and how are they recognized?
Zhou et al. (2005) pioneered the identifi-
cation of mRNA subsets associated with
eIF3 subunits by performing ribonucleo-
protein immunoprecipitation analyzed
with DNA chip (RIP-chip) experiments
with eIF3e and eiF3m, believed to form
part of two separate eIF3 complexes.
mRNAs associated with eIF3e overlap
with those translationally regulated by
the complex, suggesting that the regula-
tion is direct. More recently, two studies
used photoactivatable ribonucleoside-
enhanced crosslinking and immunopre-
cipitation (PAR-CLIP) to systematically
identify mRNAs directly associated with
eIF3 (Lee et al., 2015; Meyer et al.,
2015). The majority of eIF3 binding sites
were located in 50 UTRs, including
some on mRNAs encoding key regulators
of cell proliferation. Interestingly, Meyer
et al. (2015) found that eIF3 can be
recruited to m6-A-modified mRNA,
although how the specificity of the binding
is achieved is unclear. Approaches suchReports 16, August 16, 2016 ª 2016 1787
eativecommons.org/licenses/by-nc-nd/4.0/).
as RIP sequencing and CLIP will allow the
identification of the targets of different
eIF3 subcomplexes—physiological or
abnormal—and shed light on how eIF3
misregulation contributes to cancer.
Second, how do eIFs affect the transla-
tion of discrete mRNA sets? Inactivation
of eif3ha in zebrafish caused decreased
translation of 300 mRNAs (as measured
by polysome profiling) (Choudhuri et al.,
2013). A key observation of the prote-
ome-wide study of Shah et al. (2016) is
that eIF3e can both upregulate and
downregulate translation. A similar result
has been reported in animal cells (Lee
et al., 2015), although it was limited to
two transcripts. Future systematic studies
employing the kind of proteomic ap-
proaches used by Shah et al. (2016) or
those measuring translation with ribo-
some profiling will be required to deter-
mine the involvement of eIF3 subunits in
mRNA-specific regulation.
How does eIF3 malfunction relate to
cancer? The data from Shah et al. (2016)
suggest that this connection may arise
through global control of energy meta-
bolism via eIF3e. Given that eif3e is down-1788 Cell Reports 16, August 16, 2016regulated in some cancers (Hershey,
2015), these cells may shift to a metabolic
state that promotes proliferation. Meyer
et al. (2015) identified c-JUN as a target
of eIF3-mediated translational regulation,
suggesting that direct control of cell prolif-
eration may also underlie eIF3 role in can-
cer. In this respect, a fundamental ques-
tion is whether there are multiple eIF3
subcomplexes in animals, as is the case
in S. pombe, and whether these subcom-
plexes bind to and regulate different
mRNA sets. Detailed analysis of eIF3
complex formation indicates that differ-
ences in subunit expression levels can
lead to the formation of stable complexes
of abnormal composition (Smith et al.,
2016). If different complexes bind to
different mRNA targets (and selectively
activate or repress them), then eIF3 het-
erogeneity would explain the specific
phenotypes associated with over- and
under-expression of its subunits.
This integrative study by Shah et al.
(2016) makes an important contribution
to understanding how ‘‘core’’ compo-
nents of the translational machinery
perform gene-specific regulatory func-tions and how this regulation is coupled
to cellular phenotypes.
REFERENCES
Choudhuri, A., Evans, T., and Maitra, U. (2010).
Dev. Dyn. 239, 1632–1644.
Choudhuri, A., Maitra, U., and Evans, T. (2013).
Proc. Natl. Acad. Sci. USA 110, 9818–9823.
Hershey, J.W. (2015). Biochim. Biophys. Acta
1849, 792–800.
Jackson, R.J., Hellen, C.U., and Pestova, T.V.
(2010). Nat. Rev. Mol. Cell Biol. 11, 113–127.
Lee, A.S., Kranzusch, P.J., and Cate, J.H. (2015).
Nature 522, 111–114.
Meyer, K.D., Patil, D.P., Zhou, J., Zinoviev, A.,
Skabkin, M.A., Elemento, O., Pestova, T.V., Qian,
S.B., and Jaffrey, S.R. (2015). Cell 163, 999–1010.
Shah, M., Su, D., Scheliga, J.S., Pluskal, T., Boro-
nat, S., Motamedchaboki, K., Campos, A.R., Qi, F.,
Hidalgo, E., Yanagida, M., et al. (2016). Cell Rep.
16, this issue, 1891–1902.
Smith, M.D., Arake-Tacca, L., Nitido, A., Monta-
bana, E., Park, A., and Cate, J.H. (2016). Structure
24, 886–896.
Xue, S., and Barna, M. (2012). Nat. Rev. Mol. Cell
Biol. 13, 355–369.
Zhou, C., Arslan, F., Wee, S., Krishnan, S., Ivanov,
A.R., Oliva, A., Leatherwood, J., and Wolf, D.A.
(2005). BMC Biol. 3, 14.
